CTMX
#2609
CytomX Therapeutics, Inc. - Common Stock
3.7 0 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.60%
Monthly Change
+21.31%
6 month change
-14.15%
Year Change
+56.12%
Previous Close
3.7 6
Open
3.7 0
Low
3.7 0
High
3.7 0
Volume
80
Financials
- Market Capitalization 805.5 M
- Employee 69
- Founded 2008
- CEO N/A
- Website www.cytomx.com
- Headquarter Delaware, United States
- FIGI BBG001J472L3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-12.38
Price to sales ratio
19.31
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2588 |  REPL Replimune Group, Inc. - Common Stock | 9.94 USD | -9.55% | -14.38% | +12.83% | -13.34% | 834.41 M USD | ||
| 2592 |  IVA Inventiva S.A. - American Depository Shares | 4.30 USD | 0.00% | +11.11% | +11.69% | +28.74% | 830.92 M USD | ||
| 2632 |  ZVRA Zevra Therapeutics, Inc. - Common Stock | 13.18 USD | -1.27% | -5.79% | +2.89% | +23.87% | 779.14 M USD | ||
| 2640 |  SPRY ARS Pharmaceuticals, Inc. - Common Stock | 7.74 USD | -2.52% | -8.40% | -21.42% | -15.96% | 768.61 M USD |
Frequently asked questions about CytomX Therapeutics, Inc. - Common Stock
What is the CytomX Therapeutics, Inc. - Common Stock stock price today?
The current price of CytomX Therapeutics, Inc. - Common Stock (CTMX) is 3.7. Over the past 24 hours, the stock has changed by -1.60%. Follow the CTMX chart for real-time price dynamics.
What is the stock ticker of CytomX Therapeutics, Inc. - Common Stock?
CytomX Therapeutics, Inc. - Common Stock trades under the ticker CTMX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is CytomX Therapeutics, Inc. - Common Stock stock going up?
CTMX has changed by -3.90% over the last week, +21.31% over the last month, and +56.12% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was CytomX Therapeutics, Inc. - Common Stock net income for the last quarter?
CytomX Therapeutics, Inc. - Common Stock reported net income of -18.25 M for the last quarter. The previous quarter showed -26.51 M, which means net income changed by +31.17%.
How many employees does CytomX Therapeutics, Inc. - Common Stock have?
As of the latest available data, CytomX Therapeutics, Inc. - Common Stock has 69 employees. Workforce size can provide additional context about the company's scale and operations.
What is CytomX Therapeutics, Inc. - Common Stock EBITDA?
CytomX Therapeutics, Inc. - Common Stock EBITDA is -20.36 M, and its EBITDA margin is -198.49%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy CytomX Therapeutics, Inc. - Common Stock stock?
You can buy CytomX Therapeutics, Inc. - Common Stock (CTMX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in CytomX Therapeutics, Inc. - Common Stock stock?
Investing in CytomX Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CTMX chart and related analysis on metatrader.com as part of your research.